Giordano Pula

Has grant

Reader of Cardiovascular Biomedicine

Hull York Medical School

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giordano Pula is a Reader of Cardiovascular Biomedicine at Hull York Medical School, United Kingdom. His research focuses on the interplay between cardiovascular diseases and conditions such as diabetes and Alzheimer’s disease, emphasizing the role of platelets in inflammation and thrombosis. Recent publications include topics on platelets' behavior in various pathological states and the development of novel antithrombotic agents.

Recent Grants

Grant: Close

Cerebrovascular stress: a role for endothelial cells and platelets in Alzheimer's Disease

Open Date: 2017-02-01

Close Date: 2019-02-01

Grant: Close

Paracrine regulation of endothelial cell motility and angiogenesis by deoxyribose-1-phosphate

Open Date:

Close Date:

Grant: Close

Characterisation of the role of NADPH oxidase 1 in collagen-dependent activation of platelets: a potential target for the development of novel antithrombotics?

Open Date:

Close Date:

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (17)

Hartmut Schluter

University Professor

University Medical Center Hamburg-Eppendorf

GERMANY

Giordano Pula

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Alzheimer’s Disease–Thrombosis Comorbidity: A Growing Body of Evidence from Patients and Animal Models

Hyperactivity and Pro-inflammatory Functions of Platelets in Diabetes

Development of New Peptidomimetic NADPH Oxidase Inhibitors with Antithrombotic Properties

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery disease

Human platelets release amyloid peptides β<sub>1-40</sub> and β<sub>1-42</sub> in response to hemostatic, immune, and hypoxic stimuli

The amyloid peptide β disrupts intercellular junctions and increases endothelial permeability in a NADPH oxidase 1-dependent manner

A peptide from the staphylococcal protein Efb binds P‐selectin and inhibits the interaction of platelets with leukocytes

Identification of the factor XII contact activation site enables sensitive coagulation diagnostics

Nance-Horan Syndrome-like 1 protein negatively regulates Scar/WAVE-Arp2/3 activity and inhibits lamellipodia stability and cell migration

Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation

Diabetes and Thrombosis: A Central Role for Vascular Oxidative Stress

Protein Disulphide Isomerase and NADPH Oxidase 1 Cooperate to Control Platelet Function and Are Associated with Cardiometabolic Disease Risk Factors

Xenotropic and polytropic retrovirus receptor 1 regulates procoagulant platelet polyphosphate

Platelet-derived extracellular vesicles express NADPH oxidase-1 (Nox-1), generate superoxide and modulate platelet function

NADPH Oxidases Are Required for Full Platelet Activation In Vitro and Thrombosis In Vivo but Dispensable for Plasma Coagulation and Hemostasis

Collaborators (17)

Hartmut Schluter

Simon Ameer-Beg

Elena Lenci

Mareike G. Posner

Matthias Krause

Andrea Trabocchi

Dmitri Firsov

Stefania Marcotti

Robert Köchl

Stefan Bagby

Patrick Pagano

Evi Stavrou

Ian Eggleston

Nina Wolska

Lynn M. Butler

Gemma Little

Jonathan Gibbins

Make your next move.